Page last updated: 2024-09-03

gefitinib and leupeptins

gefitinib has been researched along with leupeptins in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (leupeptins)	Trials (leupeptins)	Recent Studies (post-2010) (leupeptins)
5,231	566	2,919	3,891	4	1,106

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, RT; Hua, C; Lv, XX; Ma, HR; Yu, JJ; Zheng, XY	1

Other Studies

1 other study(ies) available for gefitinib and leupeptins

Article	Year
EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2. Cancer medicine, 2020, Volume: 9, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gefitinib; Humans; Leupeptins; Macrolides; Male; Mice; Mouth Neoplasms; Mutagenesis; Neoplastic Stem Cells; Protein Kinase Inhibitors; Protein Stability; Proteolysis; SOXB1 Transcription Factors; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays	2020

Article

Year

EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2.

Cancer medicine, 2020, Volume: 9, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gefitinib; Humans; Leupeptins; Macrolides; Male; Mice; Mouth Neoplasms; Mutagenesis; Neoplastic Stem Cells; Protein Kinase Inhibitors; Protein Stability; Proteolysis; SOXB1 Transcription Factors; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays

2020